STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
105
13F, latest reported quarter
Conversions, 180 days
9
Codes C/M, not in net · $262.7K priced
What the filings say about TRNS
Insiders, 180 days
-$574.7K net sold
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$625.9K
1 notice
Transcat insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, TRANSCAT INC insiders sold a net $574.7K of stock across 46 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 168.2% of the 4,346 shares held after it.
1 other insider sold within 30 days.
105 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Dominach Oksana S. sold about $625.9K of TRNS on Sep 2, 2026, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 105 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Oct 8, 2024.
The trade is 252.0% of the 200 shares held after it.
1 other insider sold within 30 days.
105 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Gillette Christopher P. sold about $47.5K of TRNS on Aug 7, 2026, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 105 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on Jan 31, 2025.
+3.4% median (+4.3% mean) 90-day return after 3 previous buys.
The trade is 70.9% of the 1,480 shares held after it.
No other insider bought within 30 days.
105 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cairns Craig D. bought about $98.7K of TRNS on Aug 6, 2026, the largest insider purchase at the company since 2022; 105 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Nov 7, 2023.
+4.7% median (+4.7% mean) 90-day return after 2 previous buys.
The trade is 52.4% of the 1,910 shares held after it.
No other insider bought within 30 days.
105 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cairns Craig D. bought about $77.1K of TRNS on Jan 31, 2025, the largest insider purchase at the company since 2023; 105 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Nov 7, 2023.
+4.7% median (+4.7% mean) 90-day return after 2 previous buys.
The trade is 46.5% of the 430 shares held after it.
No other insider bought within 30 days.
105 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cairns Craig D. bought about $15.3K of TRNS on Jan 31, 2025, the largest insider purchase at the company since 2023; 105 funds added in the latest 13F quarter.
46 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
TRNS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Dominach Oksana S.
Filed 2026-09-03
$625.9K
TRNS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Osterweis Opportunity Fund
$8.6M position · as of 2026-06-30
2.2%
Buffalo Early Stage Growth Fund
$1.6M position · as of 2026-06-30
2.2%
VY(R) BARON GROWTH PORTFOLIO
$4.5M position · as of 2026-06-30
2.1%
Needham Small Cap Growth Fund
$7.1M position · as of 2026-06-30
1.7%
Meridian Contrarian Fund
$10.4M position · as of 2026-06-30
1.5%
LVIP Baron Growth Opportunities Fund
$9.9M position · as of 2026-06-30
1.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Lee D. Rudow
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$1.8M
$103.9K
$668.9K
+181%
+46%
2023
$2.4M
$2.2M
$838.3K
+320%
+82%
2022
$1.4M
$1.4M
$603.8K
+237%
+74%
2021
$1.4M
$1.5M
$598.0K
+206%
+95%
2020
$1.1M
$2.4M
$441.8K
+85%
+66%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $574.7K sold by insiders over 180 days, 105 funds added last quarter, $625.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$348.4M
four quarters, 2025-06-29 to 2026-06-27
Revenue, TTM TRNS
FY Mar 2026
n/a
FY Mar 2025
$278.4M
FY Mar 2024
$259.5M
FY Mar 2023
$230.6M
FY Mar 2022
$205.0M
Jun 2026
$92.9M
Mar 2026
$89.3M
Dec 2025
$83.9M
Sep 2025
$82.3M
Sep 2025
$82.3M
Jun 2025
$76.4M
Mar 2025
$77.1M
Dec 2024
$66.8M
At each fiscal year end
Single quarter
Net margin, TTM
+1.0%
net income over revenue, 2025-06-29 to 2026-06-27
Net margin, TTM TRNS
FY Mar 2026
n/a
FY Mar 2025
+5.2%
FY Mar 2024
+5.3%
FY Mar 2023
+4.6%
FY Mar 2022
+5.6%
Jun 2026
+1.4%
Mar 2026
+2.2%
Dec 2025
-1.3%
Sep 2025
n/a
Sep 2025
+1.5%
Jun 2025
+4.3%
Mar 2025
+5.8%
Dec 2024
+3.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$25.4M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM TRNS
FY Mar 2026
$19.6M
FY Mar 2025
$25.8M
FY Mar 2024
$19.3M
FY Mar 2023
$7.5M
FY Mar 2022
$7.5M
Jun 2026
$4.8M
Mar 2026
$2.6M
Dec 2025
$9.5M
Sep 2025
n/a
Sep 2025
$8.4M
Jun 2025
-$975.0K
Mar 2025
$7.9M
Dec 2024
$9.7M
At each fiscal year end
Single quarter
Debt to equity
0.36x
long-term 2026-06-27 plus current 2026-03-28; equity 2026-06-27
Debt to equity TRNS
FY Mar 2026
0.33x
FY Mar 2025
0.11x
FY Mar 2024
0.02x
FY Mar 2023
0.49x
FY Mar 2022
0.56x
Jun 2026
0.36x
Mar 2026
0.33x
Dec 2025
0.34x
Sep 2025
0.38x
Sep 2025
0.38x
Jun 2025
0.12x
Mar 2025
0.11x
Dec 2024
0.15x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.36x
TTM operating cash flow over long-term 2026-06-27 plus current 2026-03-28
Cash flow to debt TRNS
FY Mar 2026
0.35x
FY Mar 2025
1.19x
FY Mar 2024
7.85x
FY Mar 2023
0.35x
FY Mar 2022
0.36x
Jun 2026
0.36x
Mar 2026
0.35x
Dec 2025
0.39x
Sep 2025
0.36x
Sep 2025
0.36x
Jun 2025
0.98x
Mar 2025
1.19x
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+1.2%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on equity TRNS
FY Mar 2026
+1.8%
FY Mar 2025
+5.7%
FY Mar 2024
+8.4%
FY Mar 2023
+11.5%
FY Mar 2022
+14.1%
Jun 2026
+1.2%
Mar 2026
+1.8%
Dec 2025
+2.7%
Sep 2025
+4.0%
Sep 2025
+4.0%
Jun 2025
+4.8%
Mar 2025
+5.7%
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.8%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on assets TRNS
FY Mar 2026
+1.2%
FY Mar 2025
+4.3%
FY Mar 2024
+5.6%
FY Mar 2023
+5.7%
FY Mar 2022
+7.3%
Jun 2026
+0.8%
Mar 2026
+1.2%
Dec 2025
+1.8%
Sep 2025
+2.8%
Sep 2025
+2.8%
Jun 2025
+3.7%
Mar 2025
+4.3%
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+1.8%
operating income after a 38.6% effective tax rate, over long-term 2026-06-27 plus current 2026-03-28 plus average of 2025-06-28 and 2026-06-27 minus cash
Return on invested capital TRNS
FY Mar 2026
+2.3%
FY Mar 2025
+5.1%
FY Mar 2024
+9.4%
FY Mar 2023
+9.2%
FY Mar 2022
+9.6%
Jun 2026
+1.8%
Mar 2026
+2.3%
Dec 2025
+2.9%
Sep 2025
+3.3%
Sep 2025
+3.3%
Jun 2025
+4.6%
Mar 2025
+5.1%
Dec 2024
+5.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+2.8%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
Return on capital employed TRNS
FY Mar 2026
+3.3%
FY Mar 2025
+5.9%
FY Mar 2024
+9.4%
FY Mar 2023
+10.2%
FY Mar 2022
+11.0%
Jun 2026
+2.8%
Mar 2026
+3.3%
Dec 2025
+4.0%
Sep 2025
+4.8%
Sep 2025
+4.8%
Jun 2025
+5.5%
Mar 2025
+5.9%
Dec 2024
+6.6%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
242.56x
close 2026-10-27 over four quarters of diluted EPS, 2025-06-29 to 2026-06-27
P/E, trailing TRNS
FY Mar 2026
125.12x
FY Mar 2025
47.04x
FY Mar 2024
68.78x
FY Mar 2023
61.99x
FY Mar 2022
49.47x
Jun 2026
256.19x
Mar 2026
125.12x
Dec 2025
69.26x
Sep 2025
60.00x
Sep 2025
60.41x
Jun 2025
59.31x
Mar 2025
47.04x
Dec 2024
56.39x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$921.0M
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term 2026-06-27 plus current 2026-03-28, minus cash 2026-06-27
Enterprise value TRNS
FY Mar 2026
$760.5M
FY Mar 2025
$714.3M
FY Mar 2024
$968.3M
FY Mar 2023
$703.8M
FY Mar 2022
$603.8M
Jun 2026
$965.2M
Mar 2026
$760.5M
Dec 2025
$645.6M
Sep 2025
$789.0M
Sep 2025
$793.6M
Jun 2025
$822.9M
Mar 2025
$714.3M
Dec 2024
$1.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.1%
TTM free cash flow over market value at close 2026-10-27
FCF yield TRNS
FY Mar 2026
+2.9%
FY Mar 2025
+3.8%
FY Mar 2024
+2.0%
FY Mar 2023
+1.1%
FY Mar 2022
+1.3%
Jun 2026
+2.9%
Mar 2026
+2.9%
Dec 2025
+4.5%
Sep 2025
+3.7%
Sep 2025
+3.7%
Jun 2025
+2.5%
Mar 2025
+3.8%
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -75%, PEG needs growth
PEG, trailing TRNS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
4.38x
FY Mar 2023
n/a
FY Mar 2022
1.08x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
1.26x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
TRNS ranks highest on growth (81st percentile) and risk and compliance (62nd), and lowest on profitability (26th), among Industrials peers.
Profitability
26
Inputs
Return on equity+1.2% · 30 pct, sector of 198
Return on assets+0.8% · 37 pct, sector of 224
Return on invested capital+1.8% · 3 pct, sector of 107
Return on capital employed+2.8% · 34 pct, sector of 195
Financial health
57
Inputs
Debt to equity0.36x · 55 pct, sector of 215
Cash flow to debt0.36x · 60 pct, sector of 173
Growth
81
Inputs
Revenue growth, YoY+19.2% · 81 pct, sector of 255
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
61
Inputs
Net Form 4 buying (codes P and S), 180d-$575K · 59 pct, sector of 171
Insider buyers, 180d1 · 63 pct, sector of 173
Institutional and government
40
Inputs
Funds adding, latest quarter105 · 40 pct, sector of 200
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
62
Inputs
Short interest, % of float+4.8% · 41 pct, sector of 271
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 192
New text in Risk Factors, latest 10-K+12.0% · 45 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
TRNS filings, in plain words
Are Transcat insiders buying or selling TRNS?
In the 180 days to 2026-10-28, Transcat insiders were net sellers, a net $574.7K: $98.7K of purchases and $673.4K of sales reported on Form 4, by 1 buyer and 2 sellers.
Are there planned insider sales of TRNS?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $625.9K of stock; the latest, by Dominach Oksana S., was filed 2026-09-03.
Read the full summary
In the 180 days to 2026-10-28, Transcat insiders were net sellers of TRNS, a net $574.7K across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $625.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.